CT News and Research

RSS

Researchers identify MERS-related abnormality distribution on CT imaging of patients

Researchers in Saudi Arabia have identified key defining characteristics of Middle East Respiratory Syndrome (MERS) in CT imaging of patients confirmed as having the disease.

19 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA.

18 Jun 2014

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.

18 Jun 2014

State highlights: State retiree benefit shortfalls; health data claims and cost

A selection of health policy stories from California, Maine, Massachusetts, Maryland, New Hampshire, Virginia, Iowa, Florida, Missouri, Washington state, Connecticut, Georgia, Alabama, North Carolina and Tennessee.

18 Jun 2014

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA).

17 Jun 2014

Cover Oregon gets new chief; Mass. health law garners support; Conn. has data breach

Reports examine exchange developments in Oregon, Massachusetts, Minnesota, Washington and Connecticut.

17 Jun 2014

Study show good compliance and patient survival outcomes using LDCT screening protocol

Investigators of the COSMOS (Continuous Observation of SMOking Subjects) study show good compliance and patient survival outcomes using a 5-year low-dose computed tomography (LDCT) screening protocol in individuals at high-risk of developing lung cancer.

16 Jun 2014

Infliximab biosimilar CT-P13 improves disease activity in patients with Ankylosing Spondylitis

New data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) show that the newly-approved infliximab biosimilar CT-P13 achieves statistically similar improvements in disease activity, disability and mobility in patients with Ankylosing Spondylitis (AS) compared to its original reference product infliximab (INX).

13 Jun 2014

New advanced treatment can make huge difference for patients who suffer "brain attack"

When car crash victims suffer serious injuries, emergency crews often get them to trauma centers for the advanced care they need.

13 Jun 2014

New imaging software measures growth of nodules in patients at risk of lung cancer

Medical-imaging software under development at Rochester Institute of Technology could someday give radiologists a tool for measuring the growth of nodules in patients at risk of lung cancer, the leading cause of cancer deaths in the United States, according to the Center for Disease Control and Prevention.

13 Jun 2014

First Edition: June 12, 2014

Today's headlines include stories examining how Eric Cantor's primary defeat will change the House GOP leadership and the Republican strategy to replace the health law.

12 Jun 2014

State highlights: Calif. jails face problems with inmates with mental illness; Conn. patients to get 'facility fee' notice

Supervisor Mark Ridley-Thomas said board members and their staffs were not privy to communications sent by the U.S. Justice Department to Sheriff's Department and county mental health officials regarding ongoing problems until September. That's when county officials received a letter announcing a federal civil-rights investigation of the jail system (Sewell, 6/10).

12 Jun 2014

State highlights: Mass. near 0 percent uninsured; Ga. scraps Medicaid contract bidding; states turn to public health issues

When Massachusetts passed its landmark health coverage law under Gov. Mitt Romney in 2006, no one claimed the state would get to zero, as in 0 percent of residents who are uninsured. But numbers out today suggest Massachusetts is very close. Between December 2013 and March of this year, when the federal government was urging people to enroll, the number of Massachusetts residents signed up for health coverage increased by more than 215,000. If that number holds, the percentage of Massachusetts residents who do not have coverage has dropped to less than 1 percent (Bebinger, 6/9).

11 Jun 2014

New therapeutic interventions could render addiction into manageable disease

Neuroscientists agree that abuse of drugs hijacks circuits in the brain that are crucial for decision-making, but society as a whole tends to stigmatize addicted people for lacking self-control.

10 Jun 2014

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.

10 Jun 2014

CT News and Research

Researchers identify MERS-related abnormality distribution on CT imaging of patients

First Edition: June 18, 2014

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

State highlights: State retiree benefit shortfalls; health data claims and cost

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

Cover Oregon gets new chief; Mass. health law garners support; Conn. has data breach

Study show good compliance and patient survival outcomes using LDCT screening protocol

Infliximab biosimilar CT-P13 improves disease activity in patients with Ankylosing Spondylitis

New advanced treatment can make huge difference for patients who suffer "brain attack"

New imaging software measures growth of nodules in patients at risk of lung cancer

First Edition: June 12, 2014

State highlights: Calif. jails face problems with inmates with mental illness; Conn. patients to get 'facility fee' notice

State highlights: Mass. near 0 percent uninsured; Ga. scraps Medicaid contract bidding; states turn to public health issues

New therapeutic interventions could render addiction into manageable disease

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Children who undergo complex imaging tests may have increased risk of cancer

Enrollees' personal information may be compromised as a result of access health CT data breach

Insurers propose rate hikes for plans on the individual market

Toshiba provides new PET/CT system for radiation and oncology imaging needs

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News